BIOCRYST PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
BIOCRYST PHARMACEUTICALS INC has filed 1,953 SEC EDGAR filings since 14 Feb 1995

SEC filing history

Showing 26-50 of 1,000 matching filings.

Per page
25
Current page
2
ARS File 000-23186

ARS

Filing date
23 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-23186

DEFA14A

Filing date
23 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-23186

DEF 14A

Filing date
23 Apr 2026
Reporting date
11 Jun 2026
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Apr 2026
Reporting date
06 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
07 Apr 2026
Reporting date
06 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-44055

SCHEDULE 13G/A filing

Filing date
26 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Mar 2026
Reporting date
20 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-23186

144 filing

Filing date
20 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Mar 2026
Reporting date
16 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-23186

144 filing

Filing date
16 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2026
Reporting date
27 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2026
Reporting date
27 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2026
Reporting date
27 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2026
Reporting date
27 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2026
Reporting date
27 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-23186

144 filing

Filing date
02 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-44055

SCHEDULE 13G/A filing

Filing date
12 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-44055

SCHEDULE 13G filing

Filing date
09 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Jan 2026
Reporting date
23 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
27 Jan 2026
Reporting date
23 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-23186

FORM 8-K/A

Filing date
23 Jan 2026
Reporting date
14 Oct 2025
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .